Aria Pharmaceuticals
Growth Stage
SOUND SCIENCE
Overview
Platform
OurCrowd
Start Date
09/13/2021
Close Date
10/21/2021
Min. Goal
$10,000
Max. Goal
$2,510,000
Min. Investment
$10,000
Security Type
Convertible Note
SEC Filing Type
RegD 506(c)
Valuation Cap
$85,000,000
Discount
0%
Year Founded
2014
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Location
Palo Alto, California
Aria Pharmaceuticals, with a valuation of $85 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed an AI-driven drug delivery platform for therapeutic development candidates. The software platform helps in identifying promising hits, derisking the opportunities through preclinical studies, and progressing drug candidates to clinical trials. Aria Pharmaceuticals has already modeled over 300 diseases and has identified 1,000 diseases that it could address. Andrew A. Radin founded Aria Pharmaceuticals in 2014. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $2,510,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.